1. The Board has appointed Mr. Nand Kishore Ray (DIN: 11626638) as an Additional (Non-Executive & Non-Independent Director) of the Company w.e.f 17th April, 2026 The Board has appointed ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Johnson Pharmacare Limited's Board meeting on April 17, 2026 saw significant changes in the board composition. The company appointed two new Additional Directors - Mr. Nand Kishore Ray (Non-Executive, Non-Independent) and Mr. Dheeraj Kumar (Executive Director). Notably, Dheeraj Kumar's father is Nand Kishore Ray, indicating a family member entry to the board. Simultaneously, Mr. Rajender Parsad (Non-Executive Director) and Mr. Umesh Kumar (Executive Director) resigned citing personal and unavoidable reasons. All resigning directors confirmed no other material reasons for their departure. The appointments are effective from April 17, 2026, and both new directors are not debarred from holding director positions as per SEBI regulations.
The simultaneous resignation and appointment of two directors each raises minor governance concerns. The appointment of a father-son duo to the board may warrant scrutiny from investors regarding board independence and related party considerations. The stock is listed on BSE with code 532154.